Clinical trials: Endovascular Treatment
Abdominal Aortic Aneurysms
The Nellix® EndoVascular Aneurysm Sealing System for the Treatment of Infrarenal Abdominal Aortic Aneurysms
The purpose of this clinical study is to evaluate the safety and device performance of the Nellix® EndoVascular Aneurysm Sealing System (Nellix System) for the treatment of infrarenal abdominal aortic aneurysms.
- Trial name
- NCT02048514
- Testing
- The Nellix® EndoVascular Aneurysm Sealing System
- Where
- 4 sites in Colombia, Latvia and 2 more
- Volunteers
- 69 people
- Sponsor
- Endologix
Stroke, Cerebrovascular Disorders
Endovascular Treatment Beyond 24 Hours for Acute Ischemic Stroke Caused by Anterior Circulation Large Vessel Stenosis
Endovascular therapy (EVT) is currently recommended as the first-line treatment for patients with acute large vessel occlusion (LVO) in the anterior circulation within 24 hours of symptom onset.
- Conditions
- Stroke, Cerebrovascular Disorders, Brain Diseases, Nervous System Diseases
- Trial name
- EVT-BELATED (NCT06959199)
- Testing
- Endovascular Treatment, Best Medical Treatment
- Where
- China
- Volunteers
- 432 people
- Sponsor
- The Second Hospital of Anhui Medical University
Peripheral Arterial Disease
Predictive Value of the Global Limb Anatomic Staging System (GLASS) in Patients With Critical Limb-threatening Ischemia
The Global Vascular Guideline on chronic limb threatening ischemia (CLTI) proposes the Global Limb Anatomic Staging System (GLASS), a new angiographic scoring system to quantify the anatomic severity of infrainguinal disease in…
- Trial name
- NCT05999669
- Testing
- GLASS staging
- Volunteers
- 2,000 people
- Sponsor
- RenJi Hospital
Hepatocellular Carcinoma, Portal Vein Tumor Thrombus
Endovascular Brachytherapy Combined With Stent Placement and TACE for HCC With Main Portal Vein Tumor Thrombus
It is a prospective and multi-center clinical research in China to compare the efficacy, safety and related impact factors between TACE alone and endovascular brachytherapy combined with stent placement and TACE for HCC with main…
- Trial name
- NCT02971345
- Testing
- Stent and Iodine-125 seed strand implantation, Stent, Iodine-125 seed
- Where
- China
- Volunteers
- 253 people
- Sponsor
- Shanghai Zhongshan Hospital
Intracerebral Hemorrhage, Nontraumatic Intracerebral Hemorrhage
Detection of an Endovascular Treatment Target in Patients With an Acute, Spontaneous Intracerebral Hemorrhage
This study is to determine if a treatment target for a potential endovascular therapy exists in patients with an acute, spontaneous (non-traumatic) ICH.
- Trial name
- HemEXPLO (NCT05504941)
- Testing
- Diagnostic, cerebral Digital Subtraction Angiography (DSA)
- Where
- Switzerland
- Volunteers
- 15 people
- Sponsor
- University Hospital, Basel, Switzerland
Peripheral Arterial Disease
Cost-utility Analysis of the Outpatient Versus Conventional Hospitalization in Treatment of Occlusive Arterial Disease
The purpose of this study is to assess the efficiency of outpatient surgery compared to conventional hospitalization in endovascular treatment of occlusive arterial disease.
- Trial name
- AMBUVASC (NCT02581150)
- Testing
- Treatment of Occlusive Arterial Disease
- Where
- 11 sites in France
- Volunteers
- 160 people
- Sponsor
- Nantes University Hospital
Endovascular Treatment
Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients
To investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.
- Trial name
- NCT05988125
- Where
- 6 sites in China
- Volunteers
- 2,000 people
- Sponsor
- Tingyu-Yi
Peripheral Arterial Disease, Critical Limb Ischemia
Swedish Drug-elution Trial in Peripheral Arterial Disease
Peripheral arterial disease (PAD) causes reduced blood flow to the lower limb(s) due to stenosis or occlusion in the supplying arteries.
- Conditions
- Peripheral Arterial Disease, Critical Limb Ischemia, Intermittent Claudication
- Trial name
- SWEDEPAD (NCT02051088)
- Testing
- Revascularization with drug-eluting technology, Revascularization without drug-eluting technology, drug-coated balloons and/or drug-eluting stents
- Where
- Sweden
- Volunteers
- 3,556 people
- Sponsor
- Sahlgrenska University Hospital
Endovascular Treatment
Endovascular Treatment for AIS in Chinese Municipal and County Hospitals： A "Real World" Study-ETERNITY Registry
To investigate the Endovascular Treatment difference between Chinese city and country hospital.
- Trial name
- NCT06078917
- Where
- China
- Volunteers
- 1,196 people
- Sponsor
- Wen-huo Chen
Stroke, Large Ischemic Core
Assessing Local Hypothermia and Endovascular Recanalization for Acute Stroke With a Large Core Infarction
A multicenter, prospective, open-label, blinded-endpoint, randomized controlled trial to assess the effectiveness and safety of catheter-based focal intracranial hypothermia combined with endovascular reperfusion therapy for…
- Trial name
- RESCUE-LCI (NCT07232082)
- Testing
- intra-arterial local therapeutic hypothermia, Control (Normal saline)
- Volunteers
- 322 people
- Sponsor
- First Affiliated Hospital of Wannan Medical College
Acute Stroke
Risk Factors of Conversion From Local to General Sedation in Endovascular Stroke Therapy
Thrombectomy is now the standard of care of revascularization in acute ischaemic stroke. Data tend to show that final neurologic outcome is superior if the thrombectomy procedure was performed under conscious sedation.
- Trial name
- AMAS (NCT02895776)
- Where
- France
- Volunteers
- 28 people
- Sponsor
- Fondation Ophtalmologique Adolphe de Rothschild
Intracranial Artery Occlusion With Infarction (Disorder)
Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke (ANGEL-ACT): Phase Two
The study is the second phase of Endovascular Treatment Key Technique and Emergency Work Flow Improvement of Acute Ischemic Stroke (ANGEL-ACT).
- Trial name
- ANGEL-ACT II (NCT04151589)
- Testing
- ANGEL Intervention Package and Toolbox
- Where
- China
- Volunteers
- 664 people
- Sponsor
- Beijing Tiantan Hospital
Acute Cerebrovascular Accident, Endovascular Procedures
PROMISE (Somatosensory Evoked POtEntials MonItoring During Acute Ischemic StrokE) Study
Endovascular treatment in patients with acute ischemic stroke due to large vessel occlusion does not always lead to good clinical and functional outcome, despite achieving complete arterial recanalization.
- Trial name
- PROMISE (NCT04099615)
- Testing
- Somatosensory Evoked Potentials
- Where
- Spain
- Volunteers
- 228 people
- Sponsor
- Fundació Institut Germans Trias i Pujol
Peripheral Arterial Disease, Lower Extremity Arterial Disease
EverFlex Post Approval Study
This post-approval study is designed to confirm the long-term safety and effectiveness of the EverFlex™ Self-Expanding Stent System for the treatment of atherosclerotic superficial femoral artery (SFA) and proximal popliteal…
- Trial name
- DURABILITY PAS (NCT01680835)
- Testing
- EverFlex™ Self-Expanding Peripheral Stent System
- Where
- 23 sites in United States
- Volunteers
- 108 people
- Sponsor
- Medtronic Endovascular
Stroke, Ischemic
Triage of Patients Presenting Beyond 24 Hours With Ischemic Stroke Due to Vertebrobasilar Artery Occlusion
Endovascular thrombectomy (EVT) for posterior circulation occlusion is generally performed within a window of less than 24 hours from the time the patient was last known well (LKW).
- Trial name
- VBAO-LATE (NCT06510634)
- Testing
- Endovascular Therapy
- Where
- China
- Volunteers
- 236 people
- Sponsor
- Tianjin Huanhu Hospital
Acute Ischemic Stroke
Adjunctive Use of Intra-Arterial TNK and Albumin Following Thrombectomy
The purpose of this study is to investigate the feasibility and efficacy of intra-arterial TNK and albumin for patients with acute ischemic stroke after successful thrombectomy and whether there is a synergistic effect between…
- Trial name
- NCT06113848
- Testing
- Intra-Arterial TNK and Albumin, Intra-Arterial TNK, Intra-Arterial Albumin
- Where
- China
- Volunteers
- 80 people
- Sponsor
- Tianjin Huanhu Hospital
Hypertension,Essential
First-In-Human Study Evaluating a Novel Catheter Device in Subjects With Treatment-Resistant Hypertension
The carotid body is located at the bifurcation of the internal and external carotid arteries. It is a chemoreceptor that plays a role in the sympathetic nervous system and in the development and maintenance of hypertension.
- Trial name
- NCT03314012
- Testing
- Catheter-Based Carotid Body Ablation
- Where
- 7 sites in Australia, Czechia and 1 more
- Volunteers
- 39 people
- Sponsor
- Cibiem, Inc.
Anesthesiology, Percutaneous Coronary Intervention
Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Endovascular Cardiac Interventions
Sensory innervation of the femoral region which is the entry point for endovascular cardiac interventions such as coronary angiography,cardiac catheterization and percutaneous coronary intervention is complex.It is thought that…
- Conditions
- Anesthesiology, Percutaneous Coronary Intervention, Cardiac Catheterization, Analgesia
- Trial name
- NCT06576128
- Testing
- ultrasound, parenteral local anesthesia
- Where
- Turkey (Türkiye)
- Volunteers
- 100 people
- Sponsor
- Istanbul University - Cerrahpasa
Stroke, Stroke, Acute Ischemic
IntraCranial Atherosclerosis Related Large-vessel Occlusion Treated With Urgent Stenting (ICARUS)
The goal of this international, multi-center, randomized clinical trial is to compare two treatment options, early intracranial stenting and continued stent-retriever or aspiration based endovascular treatment, for stroke…
- Conditions
- Stroke, Stroke, Acute Ischemic, Intracranial Atherosclerosis
- Trial name
- NCT06472336
- Testing
- Intracranial stenting, Continuation of conventional endovascular therapy (EVT)
- Where
- Switzerland
- Volunteers
- 498 people
- Sponsor
- University Hospital, Basel, Switzerland
Acute Ischemic Stroke
German Stroke Registry - Endovascular Treatment
The German Stroke Registry (GSR) Endovascular Treatment is an academic, independent, prospective, multicentre, observational registry study.
- Trial name
- GSR-ET (NCT03356392)
- Testing
- telephone call d90
- Where
- Germany
- Volunteers
- 10,000 people
- Sponsor
- Universitätsklinikum Hamburg-Eppendorf